ONCOLOGY Vol 13 No 6 | Oncology

Sex Hormone Levels May Help Predict Breast Cancer Risk

June 01, 1999

Results of a study published in a recent issue of the Annals of Internal Medicine suggest that, in the near future, a simple blood test that detects levels of sex hormones could predict which women are at highest risk of developing breast cancer.

Side Effects of Prostate Cancer Radiation Treatment Modalities Differ Markedly

June 01, 1999

The side effect profiles of various therapeutic modalities used in the definitive management of prostate cancer differ significantly, reported Tamara LaCouture, MD, and colleagues at the American Society for Therapeutic Radiology and

Novel Cellular Agent Shows Promise in Treating AML

June 01, 1999

Data published in a recent issue of Blood suggest that valspodar (Amdray), a multidrug resistance modulator being developed by Novartis Pharmaceuticals Corporation, may show promise in treating certain patients with acute myelogenous leukemia

Quality of Life Apparently Unaffected by Duration of Radiation Therapy for Breast Cancer

June 01, 1999

To determine whether a shorter course of radiation treatment may be associated with an improvement in quality of life (QOL), investigators at William Beaumont Hospital, Royal Oak, Michigan, compared the QOL of women with early-

Home-Based Oral Therapy Produces Responses in Late-Stage Metastatic Breast Cancer

June 01, 1999

Baylor-Charles A. Sammons Cancer Center and Physician Reliance Network (PRN) Research recently announced data demonstrating that one in five patients with hard-to-treat metastatic breast cancers responded to capecitabine (Xeloda) even

Some Medicare Managed Care Plans Restrict Mammograms

June 01, 1999

Some Medicare managed care organizations (MCOs) are telling beneficiaries that they need to get a referral from one of the plan physicians before they can get a mammogram. But that is not what the law says. A woman can get an annual, routine

ASCO Urges Congress to Increase NIH Funding by at Least 15%

June 01, 1999

Citing the unprecedented opportunity granted by last year’s 15% increase in biomedical research funding for the National Institutes of Health (NIH), Joseph S. Bailes, MD, then president-elect of the American Society of Clinical Oncology (ASCO),

Institute of Medicine Report Criticizes Quality of Cancer Care

June 01, 1999

There are serious shortcomings in the quality of care for manyAmericans with cancer, according to a report just released by the Institute of Medicine National Cancer Policy Board. Deficits in care identified in the report include underuse of screening

Cancer Survivors’ Employment and Insurance Rights: A Primer for Oncologists

June 01, 1999

From the survivor’s viewpoint, Ms.Hoffman’s paper addresses a critical need, expressed in both its title and its conclusions: Medical professionals who treat cancer patients need to be aware of the anxieties faced by those diagnosed with cancer “so

Low-Calorie Diet Slows Prostate Cancer in Animals

June 01, 1999

New research shows that a low-calorie diet slows the progress of prostate cancer in animals. Tumor progression was inhibited irrespective of how the calories were reduced; ie, by cutting fat or carbohydrates or by changing the overall diet. The research

QOL and Outcomes Research in Prostate Cancer Patients With Low Socioeconomic Status

June 01, 1999

Adenocarcinoma of the prostate the most common solid tumor in American men, is responsible for tremendous morbidity and mortality in this country, and yet controversy governs most discussions of screening, diagnosis, and treatment. Central to any

Immunotherapy in Renal Cell Carcinoma

June 01, 1999

Very little has changed in the management of advanced renal cell carcinoma since the approval of interleukin-2 (IL-2, aldesleukin [Proleukin]) in 1992 by the FDA for the systemic treatment of this disease. Dr. Bukowski succinctly reviews the

Commentary (Horowitz): Laparoscopy in Gynecologic Malignancies

June 01, 1999

Laparoscopy dates back to 1901 when Kelling inspected a dog’s abdominal cavity with a cystoscope introduced transcutaneously. This technique was subsequently applied to humans in 1923.[1] Jacobaeus, in 1910, developed instruments

QOL and Outcomes Research in Prostate Cancer Patients With Low Socioeconomic Status

June 01, 1999

Quality of life (QOL) and health status data obtained from the Veterans Administration Cancer of the Prostate Outcomes Study (VA CaPOS) have the potential to add substantially to information available from other observational databases and

Commentary (Spirtos/Eisenkop): Laparoscopy in Gynecologic Malignancies

June 01, 1999

Minimally invasive surgery is simply the use of small incisions with specialized equipment to accomplish surgical objectives that would otherwise be completed through larger incisions with conventional equipment. A priority of gyne-cologic oncologists

Laparoscopy in Gynecologic Malignancies

June 01, 1999

One of the cornerstones of gynecologic cancer surgery is the assessment and removal of the retroperitoneal lymph nodes. Numerous reports have demonstrated that, when performed by highly skilled individuals, laparoscopic

Cancer Survivors’ Employment and Insurance Rights: A Primer for Oncologists

June 01, 1999

Cancer survivors’ access to equal employment opportunities and adequate health insurance has changed significantly during the 1990s. New federal and state laws have expanded survivors’ rights to be treated fairly in

Stable PSA Periods After adiation Therapy May Predict Disease-Free Survival

June 01, 1999

Like pretreatment prostate-specific antigen (PSA), post-treatment PSA nadirs may have prognostic significance in patients with prostate carcinoma, according to data presented by Timothy S. Boyd, MD, Robert C. Orth, BS, Wolfgang A. Tomé,

Cancer Survivors’ Employment and Insurance Rights: A Primer for Oncologists

June 01, 1999

Currently, at least 8 million individuals are alive who have survived cancer for 5 or more years.[1] By the year 2000, 1 in 900 individuals between the ages of 16 and 44 years will be survivors of childhood cancer.[2] Given these statistics, the unique

Treatment of Estrogen Deficiency Symptoms in Women Surviving Breast Cancer, Part 6

June 01, 1999

Problem: Several million women worldwide have survived breast cancer but are currently advised against the use of estrogen for the management of menopausal symptoms and for the prevention of early cardiovascular death and osteoporosis.

Immunotherapy in Renal Cell Carcinoma

June 01, 1999

Patients with metastatic renal cell carcinoma continue to present a therapeutic challenge. Current therapeutic approaches involve surgery and various types of immunotherapy. The rationale for this latter form of therapy

Postmastectomy Radiation and Survival

June 01, 1999

Based on a keynote address given by Marie Overgaard, md, at the 1998 American Society for Therapeutic Radiology and Oncology (ASTRO) meeting. Dr. Overgaard is consulting oncologist, Aarhus University Hospital, Denmark, as